The role of new biomarkers for the diagnosis and treatment of colon cancer

Magdalena Czarnecka-Czapczyńska
Dorota Bartusik-Aebisher
ID
Email src
Magdalena Krupka-Olek
David Aebisher
ID
Email src
Grzegorz Cieślar
ID
Wojciech Latos
Aleksandra Kawczyk-Krupka
ID
Email src
Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland
Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszow, University of Rzeszow, Rzeszow, Poland
Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland
Department of Photomedicine and Physical Chemistry, Medical College of Rzeszów University, Rzeszów, Poland
Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland
Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland
Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland
Received: 13 June 2021 / Revised: 15 July 2021 / Accepted: 20 July 2021 / Published: 30 December 2021

Abstract

Introduction. Colorectal cancer may be benign or malignant. According to the World Health Organization and CDC, it is the second most common cancer worldwide, after lung cancer. The mortality of colorectal cancer has been dropping for more than 20 years due to the improvements in screening techniques and treatments.

Aim. The aim of this article is to discuss the role of new biomarkers for the diagnosis and treatment of colon cancer.

Material and methods. This article is a review done in regards to discuss the role of new biomarkers for the diagnosis and treatment of colon cancer.

Analysis of the literature. A review is discussed the role of new biomarkers for the diagnosis and treatment of colon cancer using current literature.

Conclusion. The screening tests based on diagnostic new biomarkers may cause faster detection of cancer and risk factors, and provide prognostic information in order to adjust individual therapy.

 

Cite

Czarnecka-Czapczyńska M, Bartusik-Aebisher D, Krupka-Olek M, et al. The role of new biomarkers for the diagnosis and treatment of colon cancer. Eur J Clin Exp Med. 2021;19(4): 326–329. doi: 10.15584/ejcem.2021.4.7.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited